Emendo Biotherapeutics vs Intellia Therapeutics
Emendo Biotherapeutics vs Intellia Therapeutics, compared side by side on 20 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Emendo Biotherapeutics is on 59/100 and Intellia Therapeutics on 40/100.
Where each one leads
Emendo Biotherapeutics
- our overall score: 59/100 against 40/100
Intellia Therapeutics
- domain rating: 60/100 against 20/100
- funding raised: $310M against $61.0M
- LinkedIn following: 71,640 against 5,333
At a glance
| Measure | Emendo Biotherapeutics | Intellia Therapeutics |
|---|---|---|
| What it is | Developing genetic medicines and cell therapies for severe diseases using proprietary CRISPR OMNI technology. | A clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases. |
| Category | Healthcare, Genome Editing, CRISPR, Biotech | Biotech, MedTech, Genomics, Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Platform |
| Founded | 2015 | 2014 |
| Headquarters | Tel Aviv, Israel | Cambridge, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Emendo Biotherapeutics | Intellia Therapeutics |
|---|---|---|
| Employees | 41 | Not published |
| Headcount growthLast 12 months | -16.1% | Not published |
| Total funding | $61.0M | $310M |
| Latest round | Series B | Series C |
| LinkedIn followers | 5,333 | 71,640 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Emendo Biotherapeutics | Intellia Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 59/100 | 40/100 |
| Traction | 55/100 | 40/100 |
| Team | 40/100 | 70/100 |
| Search visibility | 44/100 | 31/100 |
| Quality | 68/100 | 35/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (40/100) | D (42/100) |
| Domain ratingLink authority, 0-100 | 20/100 | 60/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Emendo Biotherapeutics | Intellia Therapeutics |
|---|---|---|
| Hosting | Google Cloud | Not detected |
| CDN | Not detected | Cloudflare |
| CMS | WordPress | WordPress |
| Frameworks | Bootstrap | Jquery |
| Analytics | Google Tag Manager | Google Analytics 4, Hotjar, Fathom |
Emendo Biotherapeutics vs Intellia Therapeutics: common questions
Which is better, Emendo Biotherapeutics or Intellia Therapeutics?
On our 0-100 score Emendo Biotherapeutics rates higher (59/100 against 40/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 20 data points above: read the rows that match what you are buying for.
How do Emendo Biotherapeutics and Intellia Therapeutics compare on the numbers?
Emendo Biotherapeutics leads on our overall score (59/100 against 40/100). Intellia Therapeutics leads on domain rating (60/100 against 20/100), funding raised ($310M against $61.0M), LinkedIn following (71,640 against 5,333).
Read the full Emendo Biotherapeutics review and pricing or the Intellia Therapeutics review and pricing. You can also browse other Emendo Biotherapeutics alternatives we track.